Evidence map›Paper›PMID 33671574›Full record

ArticleViruses2021

Examination of

Adriana Ene, Taylor Miller-Ensminger, Carine R Mores, Silvia Giannattasio-Ferraz, Alan J Wolfe, Alaa Abouelfetouh, Catherine Putonti

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Strain-level genomic analysis ofMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Genomic epidemiology and characterization ofFrontiers in microbiology · 2023
    Article
  8. Whole-Genome Sequencing ofMicrobiology spectrum · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Adriana EneBioinformatics Program, Loyola University Chicago, Chicago, IL 60660, USA.
Taylor Miller-EnsmingerBioinformatics Program, Loyola University Chicago, Chicago, IL 60660, USA.
Carine R MoresDepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
Silvia Giannattasio-FerrazDepartmento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Alan J WolfeDepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.ORCID 0000-0003-4532-0545
Alaa AbouelfetouhDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria 25435, Egypt.ORCID 0000-0002-1483-0537
Catherine PutontiBioinformatics Program, Loyola University Chicago, Chicago, IL 60660, USA.ORCID 0000-0003-3049-5991
Loyola University Chicago · USAlAlamein International University · EGUniversidade Federal de Minas Gerais · BR

Funding

The Female Urinary Microbiome and Urinary IncontinenceR01DK104718 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA, WOLFE, ALAN J · 2016 to 2020
$3.1M
NIH HHS R01 DK104718
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEgyptHumansProphagesStaphylococcal InfectionsStaphylococcus aureusStaphylococcus PhagesVirulenceAnti-Bacterial AgentsEgyptprophagesPVLStaphylococcus aureus

Identifiers

PMID33671574
PMCPMC7926752
OpenAlexW3132696299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.